key: cord-0790176-d9wyt2ba authors: Laskar, Rezwanuzzaman; Ali, Safdar title: Differential mutation profile of SARS-CoV-2 proteins across deceased and asymptomatic patients date: 2021-07-23 journal: Chem Biol Interact DOI: 10.1016/j.cbi.2021.109598 sha: 71b21a5dad5e7f37cdba24b03932a8489a09c766 doc_id: 790176 cord_uid: d9wyt2ba BACKGROUND: The SARS-CoV-2 infection has spread at an alarming rate with many places showing multiple peaks in incidence. Present study analyzes a total of 332 SARS-CoV-2 genome sequences from 114 asymptomatic and 218 deceased patients from twenty-one different countries to assess the mutation profile therein in order to establish the correlation between the clinical status and the observed mutations. METHODS: The mining of mutations was carried out using the GISAID CoVSurver (www.gisaid.org/epiflu-applications/covsurver-mutations-app) with the reference sequence ‘hCoV-19/Wuhan/WIV04/2019’ present in NCBI with Accession number NC-045512.2. The impact of the mutations on SARS-CoV-2 proteins mutation was predicted using PredictSNP1(loschmidt.chemi.muni.cz/predictsnp1) which is a meta-server integrating six predictor tools: SIFT, PhD-SNP, PolyPhen-1, PolyPhen-2, MAPP and SNAP. The iStable integrated server (predictor.nchu.edu.tw/iStable) was used to predict shifts in the protein stability due to mutations. RESULTS: A total of 372 variants were observed in the 332 SARS-CoV-2 sequences with several variants present in multiple patients accounting for a total of 1596 incidences. Asymptomatic and deceased specific mutants constituted 32% and 62% of the repertoire respectively indicating their partial exclusivity. However, the most prevalent mutations were those present in both. Though some parts of the genome are more variable than others but there was clear difference between incidence and prevalence. Non-structural protein 3 (NSP3) with 68 variants had a total of only 105 incidences whereas Spike protein had 346 incidences with just 66 variants. Amongst the Deleterious variants, NSP3 had the highest incidence of 25 followed by NSP2 (16), ORF3a (14) and N (14). Spike protein had just 7 Deleterious variants out of 66. CONCLUSION: Deceased patients have more Deleterious than Neutral variants as compared to the asymptomatic ones. Further, it appears that the Deleterious variants which decrease protein stability are more significant in pathogenicity of SARS-CoV-2. The causative agent of ongoing COVID-19 global pandemic is Severe Acute Respiratory 137 The mining of non-synonymous mutations from the selected 332 sequences was done 138 utilizing the GISAID CoVSurver (www.gisaid.org/epiflu-applications/covsurver-mutations- 147 The impact of the mutations on SARS-CoV-2 proteins mutation was estimated using 148 PredictSNP1(loschmidt.chemi.muni.cz/predictsnp1) which is a meta-server integrating six predictor tools: SIFT, PhD-SNP, PolyPhen-1, PolyPhen-2, MAPP and SNAP. The SNAP and 150 PhD-SNP tools are based on supervised machine learning algorithms that have been trained 151 in massive datasets to "learn" to distinguish between pathogenic and benign variants. The 165 The iStable integrated server (predictor.nchu.edu.tw/iStable) encompasses two machine- First, the incidence of mutations with respect to gender as summarized in Fig 2A. The 186 patients for whom gender information was not available have been mentioned as unknown. There were 45 mutations (12%) present in both males and females and these variants were 188 the most prevalent ones as they accounted for around 69% of the total incidences. Also, the 189 male and female specific 221 and 75 mutations (59% and 20%) accounted for a meagre 17% 190 and 5% of the total incidence respectively. Partly this difference can be attributed to the Though there were 60 patients with unknown gender but the fact that 90% of the overall 198 mutations in the studied population is present in males, females or both means that the data from samples with unknown gender will not have much of an impact on gender wise The impact of codon bias in SARS-COV-2 genomes on incidence of mutations has been 217 reported wherein the most abundant mutations were C > U (46%), G > U (18.2%), U > C 218 (9.4%) and A > G (8.8%) implying an increase in U as a viral strategy to adapt to host codon 219 usage. This results in some mutations being more prevalent than others [21] . Evidently, in the 220 present study as well, some mutations are getting represented at a much higher rate as The timeline for accumulation of mutants has been shown in Figure 2D and evidently the 228 maximum number of mutations accrued in April 2020 wherein the incidence of COVID-19 229 was at its peak. The age wise distribution of mutants has been shown in Figure 2E . An The impact of mutations on SARS-CoV-2 proteins was assessed using three aspects as implies that a greater number of mutations does not necessarily imply higher prevalence. In order to ascertain the significance of differential incidence and prevalence, we analyzed 283 the pathogenicity of the variants as Deleterious or Neutral which has been shown in Figure 284 4b, Table 3 Table 3 ). Thus, we can say 304 that even a protein with very few mutations can be a pivotal factor in viral evolution. 315 The distribution of Deleterious and Neutral mutations across asymptomatic and deceased 316 patients has been shown in Table 3 585 586 587 588 589 590 591 592 593 594 595 596 597 598 599 600 601 602 603 604 605 606 607 608 609 610 611 612 613 614 SARS-Coronavirus-2 Nsp13 Possesses NTPase and RNA Helicase 496 Activities That Can Be Inhibited by Bismuth Salts